This Investor Sold Million: Why Biotech Shares Stay Bullish
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
Index funds and ETFs each have roles; this note explains when index funds offer a simpler, cost-effective path for many investors.
26,830 articlesA prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
Carlisle Companies stands out as a strong contender in the building products arena thanks to its diversified mix, dis...
In 2026, the commercial real estate scene is shifting. This article explains why large multifamily assets sit high on...
From a tiny boat-insurer niche to a public company, Hagerty’s story is a case study in branding, community, and strat...
Alphabet reports results after the bell, but the line that matters most might be capex. This guide shows how data-cen...
Retirees seeking reliable, recurring income can benefit from a small, focused trio of high-yielding dividend stocks. ...
A recent SEC filing shows Pale Fire Capital expanding its Ziff Davis position. This move offers clues about hedge fun...
A blockbuster IPO can set the stage for more funding moves. This article explains why spacex raising more cash throug...
As markets sway, a long-running dividend payer draws retirees seeking steady, rising income. PepsiCo's 50-plus years ...
Looking for a long-term growth plan? This article highlights three growth stocks to hold next for the next two decade...
A quarterly filing may seem dry, but it can reveal game-changing shifts in ultra-wealthy portfolios. This article exp...
A major investment bank just signaled a powerful vote of confidence in Lilly's GLP-1 strategy. This article breaks do...